Earnings Preview For Abbott Laboratories
Portfolio Pulse from Benzinga Insights
Abbott Laboratories (NYSE:ABT) is expected to release its quarterly earnings report on Wednesday, 2024-01-24, with an estimated EPS of $1.19. Investors are looking for an earnings beat and positive guidance for future growth. Historically, the company's stock price has shown mixed reactions to past earnings performances. Shares are currently trading at $114.19, with a 3.51% increase over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.
January 23, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories is anticipated to report quarterly earnings with an EPS estimate of $1.19. Past earnings have led to varied stock price reactions. Long-term trends show a 3.51% increase in share price, suggesting a positive outlook.
The anticipation of a positive earnings report and guidance from Abbott Laboratories could lead to an increase in stock price, as seen by the bullish sentiment from long-term shareholders. However, the stock has shown mixed reactions to past earnings, which introduces some uncertainty. The confidence score is not at the maximum due to the unpredictable nature of market reactions to earnings reports.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100